Copyright
©The Author(s) 2024.
World J Clin Oncol. Dec 24, 2024; 15(12): 1481-1490
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1481
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1481
Nucleotide change | Molecular consequence | Location | Number of unaffected subjects |
BRCA1 | |||
C.2158G>T | P.Glu720Ter | Exon 11 | 3 |
C.3555del | P.Glu1185fs | Exon 10 | 3 |
C.34C>T | P.Gln12Ter | Exon 2 | 2 |
C.131G>T | P.Cys44Phe | Exon 3 | 2 |
C.679G>T | P.Glu227Ter | Exon 9 | 1 |
C.4065_4068del | P.Asn1355fs | Exon 10 | 1 |
C.3679C>T1 | P.Gln1227Ter | Exon 9 | 1 |
BRCA2 | |||
C.4342_4343del | P.Asn1448fs | Exon 11 | 2 |
C.9257-1G>A | Splice acceptor | Intron 24 | 1 |
C.5804del | P.Asn1935fs | Exon 11 | 1 |
- Citation: Moukadem HA, Fakhreddine MA, Assaf N, Safi N, Al Masry A, Al Darazi M, Mahfouz R, El Saghir NS. Germline pathogenic variants among high hereditary risk patients with breast and ovarian cancer and unaffected subjects in Lebanese Arab women. World J Clin Oncol 2024; 15(12): 1481-1490
- URL: https://www.wjgnet.com/2218-4333/full/v15/i12/1481.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i12.1481